LJPC

La Jolla Pharmaceutical Stock Price

3.76
-0.03 (-0.79%)
Upgrade to Real-Time
Regular Market
3.76

Low
3.35

52 Week Range

High
7.85

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
La Jolla Pharmaceutical Company LJPC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.79% 3.76 12:52:09
Open Price Low Price High Price Close Price Prev Close
3.77 3.71 3.94 3.79
Bid Price Ask Price Spread News
3.75 3.76 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
184 37,548 $ 3.79 $ 142,336 - 3.35 - 7.85
Last Trade Time Type Quantity Stock Price Currency
12:52:14 100 $ 3.76 USD

Period:

Draw Mode:

La Jolla Pharmaceutical Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 103.29M 27.47M 17.77M $ 33.42M $ 1.16M -1.44 -5.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 698.57k 6.20%

more financials information »

La Jolla Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LJPC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.674.183.663.8692,3550.092.45%
1 Month4.804.94393.644.05146,897-1.04-21.67%
3 Months4.505.693.354.43269,258-0.74-16.44%
6 Months5.737.853.355.14295,020-1.97-34.38%
1 Year4.037.853.354.79474,133-0.27-6.7%
3 Years33.8338.392.307.70680,024-30.07-88.89%
5 Years16.0841.3592.3013.87561,306-12.32-76.62%

La Jolla Pharmaceutical Description

La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.


Your Recent History
NASDAQ
LJPC
La Jolla P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.